Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Atlanta, GA

22 studies for Crohn's Disease are recruiting at 35 sites within 50 miles of Atlanta, Georgia, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Atlanta.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Atlanta

Showing 22 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Atlanta Gastroenterology Associates-Site Number: 8400109 (Atlanta, GA); M3 Wake Research - Atlanta-Site Number: 8400028 (Sandy Springs, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest sites: Children's Center for Digestive Health Care, LLC (Atlanta, GA); Emory University School of Medicine (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    NCT05509777

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Children's Center for Digestive Health Care, LLC (Atlanta, GA); Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05923073

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Children's Center for Digestive Health Care (Atlanta, GA); Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    NCT06226883

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest sites: Atlanta Gastroenterology Associates (Part of United Digestive) (Atlanta, GA); Atlanta Gastroenterology Specialists, PC (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    NCT06233461

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Emory University Hospital, The Emory Clinic (Atlanta, GA); Atlanta Center For Gastroenterology, P.C. (Decatur, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: AGA GA Research LLC (Atlanta, GA); Digestive Healthcare of Georgia (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

    NCT06663332

    • Phase 3
    • Ages 3 years and older
    • Sex: All

    Nearest sites: Children's Center for Digestive Healthcare (Atlanta, GA); Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Atlanta Gastroenterology Associates (Atlanta, GA); Digestive Healthcare of Georgia (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Mirador Therapeutics Selected Site (Atlanta, GA); Mirador Therapeutics Selected Site (Snellville, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Children's Center for Digestive Health Care (Atlanta, GA); Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    NCT04779320

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Childrens Center For Digestive Healthcare (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT05781152

    • Phase 4
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Morehouse School Of Medicine ( Site 5071) (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Morehouse School Of Medicine (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    NCT07483073

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Atlanta Gastroenterology Associates - Peachtree Dunwoody (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

    NCT07483099

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Atlanta Gastroenterology Associates - Peachtree Dunwoody (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Morehouse School of Medicine (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

    NCT06958536

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Investigational Site Number: 8400019 (Marietta, GA)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Gastroenterology Consultants, P.C. (Roswell, GA)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Gastroenterology Consultants - Roswell /ID# 281235 (Roswell, GA)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    NCT07577843

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Atlanta Gastroenterology Specialists (Suwanee, GA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.